Prognia
Drug Database
🇪🇺EU · EMAApplication withdrawnATC: A08AA

Belviq

Obesity;Overweight

Marketing Authorisation Holder: Arena Pharmaceutical Enterprises Limited

Indication

As an adjunct to diet and exercise for weight control

Official EMA Resources

View on EMA (ema.europa.eu)

AI Drug & Interaction Analysis

Free account required

Ask Prognia AI about Belviq — dosing recommendations, drug interactions, and current guideline evidence from ESC, EMA, NICE and more.

Medical disclaimer: This information is intended for qualified healthcare professionals. Always verify with the official EMA Summary of Product Characteristics (SmPC) before clinical use.